Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites
about
Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpuraInhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulinThe proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motilityADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis.Evidence for proteolytic cleavage of brevican by the ADAMTSs in the dentate gyrus after excitotoxic lesion of the mouse entorhinal cortexDiverse impact of acute and long-term extracellular proteolytic activity on plasticity of neuronal excitabilityMatrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165Identification and characterization of ADAMTS-20 defines a novel subfamily of metalloproteinases-disintegrins with multiple thrombospondin-1 repeats and a unique GON domainThe ADAMTS metalloproteinasesAdult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury.ADAMTS4 (aggrecanase-1) interaction with the C-terminal domain of fibronectin inhibits proteolysis of aggrecan.Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysisThe C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw.Experience-dependent plasticity and modulation of growth regulatory molecules at central synapses.Multifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative DisordersADAMTS4 and ADAMTS5 knockout mice are protected from versican but not aggrecan or brevican proteolysis during spinal cord injury.Extracellular matrix: functions in the nervous systemMetzincin proteases and their inhibitors: foes or friends in nervous system physiology?Partially redundant functions of Adamts1 and Adamts4 in the perinatal development of the renal medulla.Increased expression and activity of matrix metalloproteinases characterize embolic cardiac myxomas.A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophyDeafferentation-induced redistribution of MMP-2, but not of MMP-9, depends on the emergence of GAP-43 positive axons in the adult rat cochlear nucleus.Modifications of perineuronal nets and remodelling of excitatory and inhibitory afferents during vestibular compensation in the adult mouse.Losing the sugar coating: potential impact of perineuronal net abnormalities on interneurons in schizophrenia.The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury.The extracellular matrix glycoprotein tenascin-C and matrix metalloproteinases modify cerebellar structural plasticity by exposure to an enriched environment.InSite: a computational method for identifying protein-protein interaction binding sites on a proteome-wide scale.The basic science of tendinopathy.Early postnatal expression and localization of matrix metalloproteinases-2 and -9 during establishment of rat hippocampal synaptic circuitry.Engineered Tissue Inhibitor of Metalloproteinases-3 Variants Resistant to Endocytosis Have Prolonged Chondroprotective Activity.ADAMTS expression and function in central nervous system injury and disorders.BEHAB/brevican requires ADAMTS-mediated proteolytic cleavage to promote glioma invasion.Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases.Matrix metalloproteinase-9 involvement in the structural plasticity of dendritic spines.Down-regulated genes in mouse dental papillae and pulp.Matrilin-2 is proteolytically cleaved by ADAMTS-4 and ADAMTS-5.Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function.Expression and role of the cell surface protease seprase/fibroblast activation protein-α (FAP-α) in astroglial tumors.Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells.
P2860
Q24291691-438FD837-927B-4354-B5CA-6427A08C6228Q24313406-4047E698-67E9-4784-A755-C63900A8E8C2Q24607682-5778C8BD-9CFF-4197-A7F0-8AD090CADD3FQ24810478-A76C8BD4-9082-41A3-8D9A-E4B15F40C3FCQ24811468-F17074D0-D747-4E2D-A78C-9A85EBD64A7EQ26796239-24FB978A-9D5E-43E2-9913-F8D8017191E9Q28214421-7BD6F627-6CBF-4E2E-98CD-8EF861C44BFAQ28591587-9FD4577B-89E2-4046-A5A0-57CA61F55090Q29544428-55E046CD-F771-4645-97E2-7CE10AA922AEQ30493169-47B88BD8-5D84-477F-AAF9-7FAEE681EBD3Q31065939-78F79E91-50E5-4ED5-AEA7-3F6D74FCD5BCQ33370030-05B9FE13-F30D-4A5C-8A9B-7FBCDD5DE630Q33715032-049C8676-64FF-4AE8-AB81-F37748E6ABADQ33793891-4F490F54-0130-4A90-9B92-10D0AAE30073Q33815606-11B65AA7-9DFF-4C71-A0E2-379E0FD0445AQ33854483-448CE2FA-45DC-46A2-9E3A-5E04BB6451FDQ33914563-7EAF75E0-46B5-4831-858F-3444996531DFQ34413038-3BEE5FFE-4E06-4C30-BA07-B791B8ED1F49Q34768858-2F5171EC-8F5A-4E6D-A75F-033E7713429CQ35048162-39844E84-0F40-4350-B24F-5A6A60B98AF2Q35083901-9572850B-3DD1-4A29-B401-AE1769570349Q35085903-7217F149-97DB-45EB-BB86-752662630F56Q35450323-7CA755BA-337D-4A40-9886-D626C6DA79CDQ35742989-723BD665-35FC-4F76-A29D-2D92987902CAQ35858830-A9B0D02A-95C4-4A00-8B37-6DE47193B4EEQ35907961-DEF24448-9DFA-4716-A0C4-FCBF45814655Q35992702-504D62A0-BEF0-4128-B7B1-3C1329314730Q36643290-4BE6C52F-7A6E-4196-AEA0-390044265F8AQ36826238-8867AFAE-D741-4F9B-870E-C184CE22F372Q37007600-96FAB823-78D5-4269-BEC1-1D241C3AA2E6Q37338894-983FFD08-9DF6-4B9B-9913-00F0A6B4B80CQ37346436-18E913FC-0D16-400B-83BC-188A5AD85BF0Q37494812-33102FB2-5C34-4038-98ED-2862EE5E5A06Q37769281-4FFF2118-2904-4846-B472-36CAFA7030A2Q38234888-DDFFCEF0-0FAA-4C18-BB3D-09BE70B6BA29Q38344192-65BF0B12-B063-49BF-89B2-6A9A2D32B465Q38981772-B889A302-123F-42C1-BDAB-A0B8DDFE1FC9Q39035362-0B5F5055-5DF9-4991-9C18-324A72B6B11DQ39667924-68417665-D9DB-4885-8B32-44BF80EFFBA9Q39741940-01401D31-5C2A-4AED-8C1B-F3D3A3BBD368
P2860
Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Brevican is degraded by matrix ...... 1 (ADAMTS4) at different sites
@ast
Brevican is degraded by matrix ...... 1 (ADAMTS4) at different sites
@en
Brevican is degraded by matrix ...... 1 (ADAMTS4) at different sites
@nl
type
label
Brevican is degraded by matrix ...... 1 (ADAMTS4) at different sites
@ast
Brevican is degraded by matrix ...... 1 (ADAMTS4) at different sites
@en
Brevican is degraded by matrix ...... 1 (ADAMTS4) at different sites
@nl
prefLabel
Brevican is degraded by matrix ...... 1 (ADAMTS4) at different sites
@ast
Brevican is degraded by matrix ...... 1 (ADAMTS4) at different sites
@en
Brevican is degraded by matrix ...... 1 (ADAMTS4) at different sites
@nl
P2093
P2860
P3181
P356
P1476
Brevican is degraded by matrix ...... 1 (ADAMTS4) at different sites
@en
P2093
K Sugimoto
Y Yamaguchi
P2860
P304
38885-38890
P3181
P356
10.1074/JBC.M003875200
P407
P577
2000-12-01T00:00:00Z